| Trial ID: | L4508 |
| Source ID: | NCT04303819
|
| Associated Drug: |
Exenatide Treatment
|
| Title: |
The Effect of Exenatide on Fasting Bile Acids
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus in Obese
|
| Interventions: |
DRUG: Exenatide treatment
|
| Outcome Measures: |
Primary: Plasma total bile acids in fasting state, reported in μmol/L, 12 weeks | Secondary: fasting plasma glucose, reported in mmol/L, 12 weeks|Glycated hemoglobin A1c, reported in %, 12 weeks|C-peptide, reported in mU/L, 12 weeks|Fasting serum insulin, reported in mU/L, 12 weeks|Body mess index, reported in kg/m\^2, 12 weeks
|
| Sponsor/Collaborators: |
Sponsor: Beijing Chao Yang Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
38
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2020-01-05
|
| Completion Date: |
2020-01-31
|
| Results First Posted: |
|
| Last Update Posted: |
2020-06-11
|
| Locations: |
Beijing Chao-yang hospital, Beijing, 100020, China
|
| URL: |
https://clinicaltrials.gov/show/NCT04303819
|
